You are asked to see a 72 year old lady in the ED who presented from home with a decreased level of consciousness. Bloods are not back yet, but the ED staff specialist is concerned about this ABG result.
(This is one of the older vivas, back when the college did not even bother to give you their stem text. Their entry for this viva simply reads "Diagnosis and management of hyper-glycaemic, hyper-osmolar, non-ketotic coma. Twelve out of fifteen candidates passed this section". As the consequence of this, most of what you see here is generated de novo by yours truly.)
Anyway: that gas;
The differentials must be broad, and this question tests whether the candidate will fixate on the BSL and HONK or whether they will produce a list of broad differentials. This HONKed-out patient might have also had a stroke, or a blow to the head from an elder-abusing grandchild, or they might have huffed some glue fumes, or any number of other things.
To aid the viva examiner, here is a broad list of differentials to tick off:
With focal signs Vascular causes:
Infectious causes:
Neoplastic causes
Intrinsic neurological causes
Autoimmune causes
Traumatic causes
|
Without focal signs Vascular causes:
Infectious causes:
Drug-related causes:
Intrinsic neurological cause
Autoimmune causes
Traumatic causes
Endocrine and metabolic causes:
|
With meningism Vascular causes:
Infectious causes:
|
A - own and patent
B - RR 30, SpO2 88% on 15L via non-rebreather mask
C - BP 77/35, HR 120-150 (rapid AF)
D - E1 V1 M5, localising with both upper limbs. BSL by fingerprick glucometer reads "HI".
E - Cool to the touch; axillary temperature is 33.5°C. No obvious signs of trauma.
A - Protect the airway. This patient needs to be intubated.
B - Ventilate with mandatory mode initially; aim for a lower CO2 because the metabolic acidosis is particularly severe.
C- Resucitate with fluid:
D - sedate minimally;
- send this patient for a CT brain, particularly a CT venogram
- consider anticonvulsants
E - measure osmolality
Watch for a precipitous drop in serum osmolality.
A safe drop is 3–8 mOsm/kg/h
Correct electrolyte deficit:
F - Monitor renal function and urine output; consider dialysis
G - Insulin therapy may not be required, and may even be dangerous.
BSL may decrease at a satisfactory rate with fluid resuscitation alone.
May require anticoagulation for dural sinus thrombosis.
May require antibiotics, given that infection is a common precipitant.
A septic screen should be sent.
How does one discriminate between DKA and HONK even when in about 30% of instances the two disorders coexist? Arbitrary definitions exist, proposed by the American Diabetes Association.
Domain |
Features suggestive of DKA |
Features suggestive of HONK |
Demographic |
|
|
History |
|
|
Examination |
|
|
Biochemistry |
|
|
Similarly to DKA, a stress response which mobilises metabolic substrates in a Type 2 diabetic will result in HONK.
Mismanagement of diabetes
Drugs which trigger HONK
|
Physiological stress
|
The key distinction between DKA and HONK seems to be the fact that in HONk, there is still enough insulin to overcome the ketogenic effects of glucagon.
Glucagon inhibits acetyl-CoA carboxylase, which normally converts acetyl-CoA into malonyl-CoA. Malonyl CoA inhibits acyl-carnitine synthesis; if this is uninhibited, it results in a stream of fatty acids being sucked up into the mitochondria to be converted into ketones.
Thus, we have a hyperglycaemic patient who remains reasonably asymptomatic because in them acidosis fails to develop (and thus, they are not short of breath). They remain hyperglycaemic for some time. As a result, they subject themselves to osmotic diuresis for a prolonged period, which allows them to become progressively more and more dehydrated.
The result is the hyperosmolar state which is usually associated with HONK.
This hyperosomolar hyperglycaemia is an intensely proinflammatory and prothrombotic state, which gives rise to the various complications of HONK.
RespiratoryTachypnoea Low PCO2 CardiovascularTachycardia Hypotension due to hypovolemia Biochemical High anion gap metabolic acidosis (with lactate and uremia rather than ketones) Hypokalemia (due to vomiting) Hypophosphatemia Hypomagnesemia |
NeurologicalObtundation and coma Weakness Seizures Stroke RenalAcute renal failure Polyuria Polydipsia HematologicalLeucocytosis Thrombosis |
This question may not be specific or direct enough, and the candidate may need to be further prompted, "how will you resuscitate this hypotensive patient" or "how will you manage the hyperglycaemia". In short, they are expected to discuss fluid management.
Oh's Manual suggests that there is no specific difference between the fluid management in DKA and in HONK. On the basis of this consensus statement, they recommend the following fluid resuscitation schedule for both:
Specifically, the answer should be:
The college touched on this issue in Question 24 from the first paper of 2017. Specifically, the candidates were asked for "risk factors for all patients that predispose to the development of cerebral oedema" in HONK/HHS. Turns out, in adults this is a fairly uncommon complication (Matz, 1999).
|
|
How does one avoid cerebral oedema in HHS? Though there is a real risk of cerebral oedema with vigorous fluid resuscitation, there is only some vague mention of the need to be careful. Gouveia et al (2013) and Dhatariya (2014) both authored review articles which warn of cerebral oedema and central myelinolysis. A recent Diabetes UK Position Statement (Scott et al, 2015) recommends we reduce osmolality by 3–8 mOsm/kg/h, as a safe rate.
Mortality is higher for HONK than for DKA, and the patients tend to be older. One study sheds some light on poor prognostic indicators:
The candidate needs to demonstrate an awareness of the fact that his level of hyperglycaemia is profoundly pro-inflammatory and that ceberal venous thrombosis is something that needs to be ruled out.
Disclaimer: the viva stem above may be an original CICM stem, acquired from their publicly available past papers. Or, perhaps it is a slightly altered version of the original CICM stem. Or, it is a completely original viva stem, concocted by the monstrously amoral author of Deranged Physiology for nothing more than his own personal amusement. In either case, because the college do not make the main viva text or marking criteria available, almost everything here has been confabulated. It might sound like a plausible viva and it could be used for the purpose of practice, but all should be aware that it does not represent the "true" canonical CICM viva station.
Radiometer ABL 700 operator's reference manual
UpToDate has a nice summary of this topic for the paying customer.
Oh's Intensive Care manual: Chapter 58 (pp. 629) Diabetic emergencies by Richard Keays
Umpierrez, Guillermo E., Mary Beth Murphy, and Abbas E. Kitabchi. "Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome." Diabetes Spectrum15.1 (2002): 28-36.
ARIEFF, ALLEN I., and HUGH J. CARROLL. "Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of theraphy in 37 cases." Medicine 51.2 (1972): 73-94.
Alberti, K. G. M. M., et al. "Role of glucagon and other hormones in development of diabetic ketoacidosis." The Lancet 305.7920 (1975): 1307-1311.
Kitabchi, Abbas E., et al. "Management of hyperglycemic crises in patients with diabetes." Diabetes care 24.1 (2001): 131-153.
Hyperglycemic Comas by P. VERNON VAN HEERDEN from Vincent, Jean-Louis, et al. Textbook of Critical Care: Expert Consult Premium. Elsevier Health Sciences, 2011.
Oh's Intensive Care manual: Chapter 58 (pp. 629) Diabetic emergencies by Richard Keays
Umpierrez, Guillermo E., Mary Beth Murphy, and Abbas E. Kitabchi. "Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome." Diabetes Spectrum15.1 (2002): 28-36.
ARIEFF, ALLEN I., and HUGH J. CARROLL. "Nonketotic hyperosmolar coma with hyperglycemia: clinical features, pathophysiology, renal function, acid-base balance, plasma-cerebrospinal fluid equilibria and the effects of theraphy in 37 cases." Medicine 51.2 (1972): 73-94.
Gerich, John E., Malcolm M. Martin, and Lillian Recant. "Clinical and metabolic characteristics of hyperosmolar nonketotic coma." Diabetes 20.4 (1971): 228-238.
Kitabchi, Abbas E., et al. "Hyperglycemic crises in adult patients with diabetes." Diabetes care 32.7 (2009): 1335-1343.
Kitabchi, Abbas E., et al. "Hyperglycemic crises in adult patients with diabetes a consensus statement from the American Diabetes Association." Diabetes care 29.12 (2006): 2739-2748.
Ellis, E. N. "Concepts of fluid therapy in diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic coma." Pediatric clinics of North America 37.2 (1990): 313-321.
Pinies, J. A., et al. "Course and prognosis of 132 patients with diabetic non ketotic hyperosmolar state." Diabete & metabolisme 20.1 (1993): 43-48.
Gouveia, Catherine F., and Tahseen A. Chowdhury. "Managing hyperglycaemic emergencies: an illustrative case and review of recent British guidelines." Clinical Medicine 13.2 (2013): 160-162.
Dhatariya, Ketan. "Diabetic ketoacidosis and hyperosmolar crisis in adults." Medicine 42.12 (2014): 723-726.
Scott, A. R. "Management of hyperosmolar hyperglycaemic state in adults with diabetes."Diabetic Medicine 32.6 (2015): 714-724.
Matz, R. O. B. E. R. T. "Management of the hyperosmolar hyperglycemic syndrome." American family physician 60.5 (1999): 1468-1476.
Matz, R. "How big is the risk of cerebral edema in adults with DKA." J Crit Illn 11 (1996): 768-772.
Kitabchi, Abbas E., et al. "Hyperglycemic crises in adult patients with diabetes." Diabetes care 32.7 (2009): 1335-1343.
Quintana, E. C. "Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema." Annals of Emergency Medicine 43.6 (2004): 793-794.
Bialo, Shara R., et al. "Rare complications of pediatric diabetic ketoacidosis."World journal of diabetes 6.1 (2015): 167.
Lawrence, Sarah E., et al. "Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis." The Journal of pediatrics 146.5 (2005): 688-692.
Marcin, James P., et al. "Factors associated with adverse outcomes in children with diabetic ketoacidosis-related cerebral edema." The Journal of pediatrics 141.6 (2002): 793-797.
Glaser, Nicole, et al. "Risk factors for cerebral edema in children with diabetic ketoacidosis." New England Journal of Medicine 344.4 (2001): 264-269.
Rosenbloom, Arlan L. "Intracerebral crises during treatment of diabetic ketoacidosis." Diabetes care 13.1 (1990): 22-33.